GDNF and alcohol use disorder
- PMID: 29726054
- PMCID: PMC6215739
- DOI: 10.1111/adb.12628
GDNF and alcohol use disorder
Abstract
Glial cell line-derived neurotrophic factor (GDNF) has been extensively studied for its role in the development and maintenance of the midbrain dopaminergic system, although evidence suggests that GDNF also plays a role in drug and alcohol addiction. This review focuses on the unique actions of GDNF in the mechanisms that prevent the transition from recreational alcohol use to abuse. Specifically, we describe studies in rodents suggesting that alcohol acutely increases GDNF expression in the ventral tegmental area, which enables the activation of the mitogen-activated protein kinase signaling pathway and the gating of alcohol intake. We further provide evidence to suggest that GDNF acts in the ventral tegmental area via both nongenomic and genomic mechanisms to suppress alcohol consumption. In addition, we describe findings indicating that when this endogenous protective pathway becomes dysregulated, alcohol intake levels escalate. Finally, we describe the potential use of GDNF inducers as a novel therapeutic approach to treat alcohol use disorder.
Keywords: GDNF; addiction; alcohol; ethanol; mesolimbic system; nucleus accumbens; ventral tegmental area.
© 2018 Society for the Study of Addiction.
Figures



Similar articles
-
Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse.Addict Biol. 2015 Jul;20(4):629-42. doi: 10.1111/adb.12152. Epub 2014 May 6. Addict Biol. 2015. PMID: 24801661
-
Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption.J Neurosci. 2005 Jan 19;25(3):619-28. doi: 10.1523/JNEUROSCI.3959-04.2005. J Neurosci. 2005. PMID: 15659598 Free PMC article.
-
GDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking.Addict Biol. 2014 Jul;19(4):623-33. doi: 10.1111/adb.12028. Epub 2013 Jan 9. Addict Biol. 2014. PMID: 23298382 Free PMC article.
-
GDNF and addiction.Rev Neurosci. 2005;16(4):277-85. doi: 10.1515/revneuro.2005.16.4.277. Rev Neurosci. 2005. PMID: 16519005 Review.
-
GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease.FEBS Lett. 2015 Dec 21;589(24 Pt A):3760-72. doi: 10.1016/j.febslet.2015.11.006. Epub 2015 Nov 7. FEBS Lett. 2015. PMID: 26555190 Review.
Cited by
-
Alterations in anthropometric, inflammatory and mental health parameters during Ramadan intermittent fasting in a group of healthy people: a prospective cohort study.Front Nutr. 2024 Feb 1;11:1298281. doi: 10.3389/fnut.2024.1298281. eCollection 2024. Front Nutr. 2024. PMID: 38362105 Free PMC article.
-
Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration.Int J Mol Sci. 2020 Sep 8;21(18):6575. doi: 10.3390/ijms21186575. Int J Mol Sci. 2020. PMID: 32911810 Free PMC article. Review.
-
Neurotrophins and Other Growth Factors in the Pathogenesis of Alzheimer's Disease.Life (Basel). 2023 Feb 26;13(3):647. doi: 10.3390/life13030647. Life (Basel). 2023. PMID: 36983803 Free PMC article. Review.
-
Gut microbiome-brain-cirrhosis axis.Hepatology. 2024 Aug 1;80(2):465-485. doi: 10.1097/HEP.0000000000000344. Epub 2023 Mar 6. Hepatology. 2024. PMID: 36866864 Free PMC article. Review.
-
DNA methylation and regulation of gene expression: Guardian of our health.Nucleus (Calcutta). 2021;64(3):259-270. doi: 10.1007/s13237-021-00367-y. Epub 2021 Aug 16. Nucleus (Calcutta). 2021. PMID: 34421129 Free PMC article. Review.
References
-
- Adams JP, Anderson AE, Varga AW, Dineley KT, Cook RG, Pfaffinger PJ, Sweatt JD. The A-type potassium channel Kv4.2 is a substrate for the mitogen-activated protein kinase ERK. J Neurochem. 2000;75:2277–2287. - PubMed
-
- Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nature reviews Neuroscience. 2002;3:383–394. - PubMed
-
- Airavaara M, Planken A, Gaddnas H, Piepponen TP, Saarma M, Ahtee L. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. The European journal of neuroscience. 2004;20:2336–2344. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA014366/AA/NIAAA NIH HHS/United States
- 1916-13/ISF/International
- R01 AA016848/AA/NIAAA NIH HHS/United States
- NARSAD 19114/Brain and Behavior Research Foundation/International
- I-2348-105.4/2014/GIF/International
- K99 AA021802/AA/NIAAA NIH HHS/United States
- Israel Antidrug Authority/International
- 968-13/ISF/International
- K99/R00 AA021802/AA/NIAAA NIH HHS/United States
- 1916-13 968-13/ISF/International
- R00 AA021802/AA/NIAAA NIH HHS/United States
- National Institute for Psychobiology in Israel/International
- R37 AA016848/AA/NIAAA NIH HHS/United States
- P50 AA017072/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical